The global market for micro servers is observing massive call for competent computing goods, which has obliged market players to upturn their concentration on product invention and development of the current assortment. Mergers, acquisit…
BMI View: Although we see limited chances for Portugal to improve its competitiveness in order to attract
foreign investment in the near future, rising private consumption and fiscal policy will support
pharmaceutical and healthcare market growth rates over a multi-quarter horizon. In addition, as the
economy continues to recover, the expansion of healthcare coverage will support rising demand for medical
treatment. That said, cost-control measures will translate to marginal pharmaceutical sales growth,
weighing on the market potential appeal for drugmakers.
Headline Expenditure Projections
- Pharmaceuticals: EUR3.44bn (USD3.81bn) in 2015 to EUR3.45bn (USD3.70bn) in 2016; +0.3% in
local currency and -3.2% in US dollar terms. Forecast broadly in line with the last quarter.
- Healthcare: EUR16.71bn (USD18.54bn) in 2015 to EUR16.98bn (USD18.17bn) in 2016; +1.6% in local
currency and -2.0% in US dollar terms. Forecast broadly in line with the last quarter.